Hemorrhagic Shock After Neonatal Circumcision: Severe Congenital Factor XIII Deficiency

Overview

Journal Case Rep Pediatr

Publisher Wiley

Specialty Pediatrics

Date 2021 May 19

PMID 34007504

Authors

Erin L Cohen

Samantha E Millikan

Perry C Morocco

Jill L O de Jong

Affiliations

Soon will be listed here.

Abstract

A Caucasian male infant born full term via normal spontaneous vaginal delivery was given vitamin K after birth, circumcised on day of life (DOL) 1, and discharged from the nursery on DOL 2. At the time of circumcision, oozing from the surgical site was noted and initially resolved with silver nitrate. Over the next two days, he presented to local emergency rooms multiple times for recurrent bleeding, eventually developing hemorrhagic shock resulting in admission to the neonatal intensive care unit. After extensive work up, he was ultimately diagnosed with severe congenital factor XIII deficiency. Congenital factor XIII deficiency is a rare bleeding disorder characterized by normal prothrombin time (PT) and activated partial thromboplastin time (aPTT) coagulation labs on routine screening, and has a high risk of complications, such as spontaneous intracranial hemorrhage. Although uncommon, when caring for a child with bleeding, physicians must have a high index of suspicion to make this diagnosis in order to initiate proper treatment and start prophylaxis given the risk of morbidity and mortality in untreated patients.

References

Peyvandi F, Palla R, Menegatti M, Siboni S, Halimeh S, Faeser B . Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012; 10(4):615-21. DOI: 10.1111/j.1538-7836.2012.04653.x. View

Dorgalaleh A, Rashidpanah J . Blood coagulation factor XIII and factor XIII deficiency. Blood Rev. 2016; 30(6):461-475. DOI: 10.1016/j.blre.2016.06.002. View

Kerlin B, Inbal A, Will A, Williams M, Garly M, Jacobsen L . Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results. J Thromb Haemost. 2017; 15(8):1601-1606. DOI: 10.1111/jth.13748. View

Anwar R, Minford A, Gallivan L, Trinh C, Markham A . Delayed umbilical bleeding--a presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics. 2002; 109(2):E32. DOI: 10.1542/peds.109.2.e32. View

Karimi M, Peyvandi F, Naderi M, Shapiro A . Factor XIII deficiency diagnosis: Challenges and tools. Int J Lab Hematol. 2017; 40(1):3-11. DOI: 10.1111/ijlh.12756. View

Ichinose A . Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients. Blood Rev. 2016; 31(1):37-45. DOI: 10.1016/j.blre.2016.08.002. View

Solomon C, Korte W, Fries D, Pendrak I, Joch C, Groner A . Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data. Transfus Med Hemother. 2016; 43(5):365-373. PMC: 5073543. DOI: 10.1159/000446813. View

Mehta R, Shapiro A . Plasminogen activator inhibitor type 1 deficiency. Haemophilia. 2009; 14(6):1255-60. DOI: 10.1111/j.1365-2516.2008.01834.x. View

Killick C, Barton C, Aslam S, Standen G . Prenatal diagnosis in factor XIII-A deficiency. Arch Dis Child Fetal Neonatal Ed. 1999; 80(3):F238-9. PMC: 1720920. DOI: 10.1136/fn.80.3.f238. View

10.

Kessel R, Hu C, Shore-Lesserson L, Rand J, Manwani D . A child with acquired factor XIII deficiency: case report and literature review. Haemophilia. 2013; 19(6):814-26. DOI: 10.1111/hae.12145. View

11.

Fadoo Z, Saleem A . Factor XIII deficiency in children--clinical presentation and outcome. J Coll Physicians Surg Pak. 2008; 18(9):565-8. DOI: 09.2008/JCPSP.565568. View

12.

Acharya S . Rare bleeding disorders in children: identification and primary care management. Pediatrics. 2013; 132(5):882-92. DOI: 10.1542/peds.2012-3662. View

13.

Kohler H, Ichinose A, Seitz R, Ariens R, Muszbek L . Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2012; 9(7):1404-6. DOI: 10.1111/j.1538-7836.2011.04315.x. View

14.

Carpenter S, Mathew P . Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance. Haemophilia. 2009; 14(6):1250-4. DOI: 10.1111/j.1365-2516.2008.01766.x. View

15.

Muszbek L, Bereczky Z, Bagoly Z, Komaromi I, Katona E . Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011; 91(3):931-72. DOI: 10.1152/physrev.00016.2010. View

16.

Caudill J, Nichols W, Plumhoff E, Schulte S, Winters J, Gastineau D . Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion. 2009; 49(4):765-70. DOI: 10.1111/j.1537-2995.2008.02021.x. View

17.

Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci P . Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost. 2003; 1(8):1852-3. DOI: 10.1046/j.1538-7836.2003.00338.x. View

18.

Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Hosseini S, Shamsizadeh M . Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol. 2014; 100(5):443-9. DOI: 10.1007/s12185-014-1664-1. View

19.

Tahlan A, Ahluwalia J . Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit. Arch Pathol Lab Med. 2014; 138(2):278-81. DOI: 10.5858/arpa.2012-0639-RS. View

20.

Hsieh L, Nugent D . Factor XIII deficiency. Haemophilia. 2009; 14(6):1190-200. DOI: 10.1111/j.1365-2516.2008.01857.x. View